Abstract:
In an interview, Dr Chuck Cochran
discusses the anti-arthritic and anti-aging qualities of Cetyl
Myristoleate (CM), an oil product.
| Full Text: |
| Copyright Trio Publications Feb/Mar
1999 |
totalhealth: Dr. Cochran, before we get started discussing some of the exciting results
that you have found using Cetyl Myristoleate (CM), would you please give our readers a
little of your background? Dr. Cochran: I would be happy to. I received my doctorate in
chiropractic from Palmer College of Chiropractic in 1984.
Since that time my post-graduate education has included programs in the operation and
diagnostic procedures of scanning and liquid crystal thermography, the philosophy and
clinical techniques of acupuncture and clinical nutrition. Actually I grew up in a
chiropractic family. My stepfather and brother are graduates of Palmer College and my
mother spent almost 40 years in my father's office doing nutritional counseling. She was
way ahead of her time and taught me quite a bit. I have also had the opportunity to teach
college level human anatomy and physiology and I presently own a company that does
consulting for the nutritional industry and specializes in creating nutritional formulas.
I am the author of the booklet "Dr. Chuck Cochran Discusses Arthritis and Cetyl
Mvristoleate."
TH: For those of our readers who are unfamiliar with cetyl myristoleate, would you
please describe it for us?
Dr. C: Cetyl myristoleate, sometimes just referred to as CM, is an oil product. At room
temperature it has a smooth, runny texture to it. For professional chemists out there, it
is the hexadecyl or cetyl alcohol ester of the unsaturated fatty acid cis-9tetradecenoic
acid, more commonly known as myristoleic acid. In other words, for those non-chemists like
me, a cetyl alcohol molecule is added to the fatty acid, myristoleic acid, and the ester,
cetyl myristoleate, is created.
TH: So cetyl myristoleate is synthesized. Does it occur naturally as well?
Dr. C: Yes, cetyl myristoleate has been isolated in several different animals including
the mouse, the male beaver, sperm whales and a couple of species of rats. So far it has
not been found in any plants. However, there are plant sources of myristoleic acid which
can then be used to create the cetyl myristoleate.
TH: We have heard that cetyl myristoleate is effective in treating arthritis. Is this
true?
Dr. C: Yes, I have found it effective in addressing some of the causes and many of the
symptoms of the various forms of arthritis. You know, the term arthritis is technically
not a medical diagnosis. It is a general term that describes a symptom of inflammation
(-itis) of a joint (arthro). It is also a term used to describe over 100 different
conditions that involve inflammation, pain, swelling and restricted ranges of motion of
the joints and/or surrounding tissues in the body.
Arthritis comes with many different faces. One type, known as rheumatoid arthritis
(RA), is a result of an overactive immune system that can no longer differentiate self
from non-self and starts to attack normal, healthy tissues in the body. The most common
type, known as osteoarthritis or degenerative joint disease (DJD), is a result of the
destruction of joint cartilage due to wear-and-tear over time, abnormal skeletal
biomechanics, a major injury to the joint, or a series of minor injuries known as
repetitive stress injuries. Another type that primarily affects the distal joints of the
fingers and toes, but can also cause severe crippling, is associated with psoriasis and
thus is referred to as psoriatic arthritis. A couple of other conditions we hear a lot
about these days and that account for over 20 percent of the visits to the rheumatologist
are fibromyalgia and polymyalgia rheumatica. Fibromyalgia affects muscles and tendons, not
the joints. It normally occurs in younger women, whereas polymyalgia rheumatica includes
the joints, as well as other connective tissues, and is found in older women. All of these
conditions respond very well with CM treatment.
TH: How do so many different forms of arthritic conditions, with so many different
causes, respond to one treatment?
Dr. C: The only explanation is that CM operates in at least four different ways. First,
and one of its most exciting functions, is that of an immunomodulator or an immune system
regulator. It has the ability to calm down hyper immune responses and so we see favorable
results in treating conditions such as rheumatoid arthritis. Second, it has
anti-inflammatory effects. Not only does it work well in addressing the symptoms of what
we call true inflammatory arthritis, but also other conditions in which inflammation can
have damaging effects, such as prostatitis and myofascitis. One of the first things we
hear from patients shortly after starting CM treatment is that they lose their morning
stiffness. Even before that first cup of coffee and hot shower, they feel loose and able
to move around smoothly and quickly.
Finally, CM treatment has analgesic or pain-killing effects. My personal belief is that
the reduction in pain is due to the antiinflammatory qualities of the cetyl myristoleate.
It only makes sense that once the swelling has gone down within the affected tissues, the
pressure against the pain-sensitive nerve endings is reduced and consequently pain is
reduced as well.
TH: How effective is CM treatment? Are there any other products that can be used to
increase the percentages of results?
Dr. C: A recent double-blind placebo study was performed on 431 patients who had been
diagnosed with rheumatoid arthritis, degenerative joint disease and psoriatic arthritis.l
The study divided this large group into three smaller groups. Group one received only
cetyl myristoleate; the second group received cetyl myristoleate combined with glucosamine
hydrochloride, sea cucumber and hydrolyzed cartilage. The third group received the
placebo. They received this treatment over a one-month period. There were 13 different
parameters evaluated including blood values, physical findings, pain assessment, doctor
evaluation and patient assessment questionnaires. The first group experienced a 64 percent
improvement while the second group saw an overall 88 percent improvement. The placebo
group improved only 14.5 percent. By combining other very safe, natural products with the
cetyl myristoleate, results can be dramatically improved. I wish this study had been done
over a three-month period or the CM doses had been increased. I am sure results would have
been even more impressive.
My own clinical experience shows similar results to the study. I've had considerable
clinical experience with CM over the past several years, having been among the very first
practitioners to use it with patients. I have observed that many of them obtained
significant relief in relatively short periods of time, often in four weeks or less. By
using other nutrients, such as boswellia serrata, turmeric, flaxseed oil, vitamin C,
manganese, zinc and copper, success rates also increase. For those with decreased
digestive function, enzyme therapy is essential. We have found that the liver is
intimately involved with how well CM functions. So for those with a history of prolonged
drug use or liver and gallbladder problems, I often recommend some sort of liver support
prior to the CM treatment. This will also increase the rate of improvement.
TH: Why do you refer to cetyl myristoleate as an anti-aging nutrient?
Dr. C: To explain this I need to talk about hormone-like molecules found throughout
tissues in the body called prostaglandins or leukotrienes. They are very powerful
molecules whose effects are local. In other words, they are produced and used in the very
same tissues, unlike hormones, which are produced in certain tissues (glands) and utilized
in other tissues or organs. When attempting to determine how cetyl myristoleate functions
in the body, I looked at other fatty acids required in our diets, like the omega-3 and
omega-6 oils. Our body uses these essential fatty acids to produce either favorable or
unfavorable prostaglandins and leukotrienes. I believe that CM treatment somehow
manipulates the good over the bad prostaglandins and leukotrienes and truly has anti-aging
effects.
There are three basic groups of prostaglandins. Prostaglandins of the first and third
series are the ones that we term good or favorable. Prostaglandins of the second series
and leukotrienes, commonly referred to as eicosanoids, are the bad or unfavorable ones. To
explain why we term them good or bad, let's take a look at how some of them function in
the body. Prostaglandins of the first and third series help to relax blood vessels and
improve circulation, reduce cholesterol made in the liver, improve functioning of T-cells
which destroy foreign invaders, reduce proliferation of immune cells that can over-react,
reduce release of histamine in allergic reactions and reduce pain and inflammation. They
also relax bronchial tubes to make breathing easier, suppress release of insulin from the
pancreas and stimulate release of human growth hormone. Prostaglandins second series, the
bad ones, produce pain and inflammation, depress immune function and induce the kidneys to
retain salt, leading to water retention and high blood pressure. Meanwhile, there are
certain leukotrienes that cause bronchial constriction in those with asthma and others
that help to cause an increase in tissue damage in autoimmune disorders. If a nutrient has
the ability to modulate and balance these very powerful chemicals, it would have great
anti-aging capabilities.
TH: Cetyl myristoleate is often referred to as CMO. Why do you call it CM?
Dr. C: CMOT is a trademarked product, cerasomal cis-9 cetyl myristoleate, an analog of
cetyl myristoleate. An analog means a similar molecule. I have communicated with a major
distributor of this product and was told that there is very little, if any, cetyl
myristoleate in their product. Interestingly, the original research, performed by Harry W
Diehl during a twoyear period from 1962 to 1964, did evaluate for several analogs,
including cetyl myristate, cetyl oleate and cetyl elaidate. He found that only cetyl
myristoleate had any significant effects.2 The one double blind placebo study used cetyl
myristoleate and not CMOT. They are different products.
TH: Have you found any side effects with CM treatment?
Dr. C: Yes, in a very small percentage (one percent) of the population, there can
be a temporary increase in symptoms. This can last for up to a week. Oftentimes this
period of time can be reduced or completely eliminated by increasing (doubling) the daily
recommended dose.
In some patients CM treatment can also cause mild stomach discomfort, nausea or loose
stools. This is usually caused by an inability to digest oils and can usually be remedied
by supplementing with lecithin to emulsify the oil, and digestive enzymes, particularly
the enzyme lipase, which helps to break down oil.
TH: What is the recommended dose for CM treatment?
Dr. C: A good dose of CM is somewhere between 10 grams and 15 grams over a three- to
four-week period. This is a good therapeutic dose and a good place to start since most
individuals (over 60 percent) will see some results with these dosages. There are some
individuals who require double this amount. After the desired results are seen, some
people require smaller maintenance doses of one or two grams per month.
TH: Finally, to whom would you recommend CM?
Dr. C: I recommend CM for anyone who suffers from muscle pain, swelling, restricted
ranges of motion and inflammation as well as those who have degenerative or inflammatory
diseases. One of the first individuals to receive exceptional results from CM treatment
had been diagnosed with non-infective prostatitis. CM in lower doses, say about one gram a
month, can be useful as a preventative and anti-aging nutrient in people over the age of
45. We will be seeing a lot more research being published on this remarkable nutrient in
the coming years.
[Reference]
References:
[Reference]
1. Siemandi, H., M.D., Ph.D., et al.
"The Effect of cis-9-Cetyl Myristoleate (CMO) And Adjunctive Therapy On The Course Of
Arthritic Episodes In Patients With Various Auto-Immune Diseases Characterized By The
Common Terminology, "Arthritis" And "Psoriasis". The Townsend Letter
for Doctors and Patients Aug/Sept (1997).
2. Diehl, H., May, E.L. "Cetyl Myristoleate Isolated from Swiss Albino Mice: An
Apparent Protective Agent Against Adjuvant Arthritis in Rats," Journal of
Pharmaceutical Science March (1994). Vol. 83.